About Products Applications Case Studies Articles FAQ How to buy

Contact us

Interested in finding out more about the CellMaker? Simply complete the form below and a member of our team will contact you.

Sitemap

Landing Pages

Customise your Controller
Request more information
NanoscaleLABS
Black Friday 2020
Rent a CellMaker
bacteriophage
Book a demo – mammalian
KUL case study
Book a demo – phage
Mammalian Research – Pivotal Scientific
Mammalian research

Campaigns by PluginOps Optin Builder

Global Rows

Pages

Posts

IBioIC's 9th Annual Conference
ISCT 2023 - International Society for Cell and Gene Therapy
Pivotal Links 2023
Microbiology Society Annual Conference 2023
Advanced Therapies 2023 Conference
Manufacturing Safe and Sustainable Plant Biomolecules using CellMakers
Efficiency of liquid mixing and volumetric mass transfer coefficient in the CellMaker bioreactor systems.
PHAGE FUTURES AND MICROBIOME CONNECT (USA) 2022
FARMAFORUM 2022
WoTS 2022 - WORLD OF TECHNOLOGY AND SCIENCE
7th BIOPRODUCTION CONGRESS: 29-30th September
WATCH: An Introduction to the CellMaker
Viruses of Microbes: 18 - 22 July
Innovate UK GBIP Biomanufacturing for Advanced Therapies - Canada
Phage Futures EU: 6 & 7 July
Edinburgh Infectious Diseases Symposium: 23 June
Analytica: 21 - 24 June 2022
Pivotal Scientific Links: 8 & 9 June 2022
IBioIC Annual Conference: 6 & 7 June 2022
EMBL in the UK 2022: Translating Discovery into Impact: 30 May 2022
Inward AMR Innovation Mission to the UK: 20 May 2022
BioDundee: 17 May 2022
Cellexus partner with Verder to upgrade bioreactor systems
Cellexus welcomes new Sales Director
AMR Conference: 7 & 8 April
PRESS: Cellexus commit to quality with ISO 9001:2015 certification
PRESS: Cellexus partner with Scottish company CB Technology
Why Choose Airlift Technology
Product Brochure
Cell and Gene Therapy with the CellMaker Low Flow Bioreactor System
New 4L CellMaker Bioreactor Bags
Singapore inaugural symposium on bacteriophage and bacteriophage derived technologies: 10 December
White Paper: Amplification and transfection of CHO suspension cells in the CellMaker Low Flow bioreactor
The Phage Maker: Making your bioreactor work for you
Infographic: The Phage Maker
Study shows the CellMaker outperforms traditional stirred tank reactor in production of carotenoids
Best Cell Culture & Fermentation Technology 2021: The CellMaker Range
18th Annual Bioprocess UK Conference 2021: 23 - 25 November
Phage Futures Europe: 23 & 24 November
Cell & Gene at the Abbey: 10 - 12 November
Scottish Life Sciences Association Annual Meeting: 4 November 2021
Farmaforum: 3 & 4 November
The Modern Laboratory: Single Use technologies vs traditional solutions
DiaLabXpo: 22 & 23 September
LabDays Aarhus: 15 & 16 September
Bacteriophage Therapy Hybrid Summit: 13 & 14 September
Phages 2021: 7 & 8 September
Cellexus partner with Abertay University
Most Pioneering Biotech Company (UK) 2021
IBioIC Member Summer Event: 17 June 2021
Cellexus receive Innovate UK grant
Leading Pioneers in Single-Use Airlift Bioreactor Technology 2021
BioDundee: 12 May 2021
Overproduction of His6-tagged recombinant protein from E. coli
Introducing the new CellMaker distributors
Joint Meeting on Vascular Biology, Inflammation and Thrombosis 2021
SY-Stem 2021: 3 - 5 March 2021
Join our Panel at the Phage Futures Congress 2021
Manufacturing phages for livestock farming featured in Capsid & Tail
PHAVES 8: Fixed Phage & Cellexus on scaling up phage production
We’ve joined the IBioIC community
IBioIC Annual Conference 2021: 10 & 11 February
Infographic: 2020 in numbers
Infographic: Should I rent or purchase my CellMaker?
Most Pioneering Bioreactor Range 2020
Using the CellMaker to manufacture bacteriophage as ft in Capsid & Tail
Phages 2020: the highlights
3 Key Takeaways from the Bacteriophage Therapy Summit
Annual Meeting of the Austrian Association of Molecular Life Sciences
Phages 2020: 9 & 10 September
LabDays: 2 & 3 September 2020
Bacteriophage Therapy Summit: 27 & 28 August 2020
Meet the Team: Adam Ostrowski
Remote installation now available
Case Study: Phage Amplification for Crop Protection with KU Leuven
Case Study: Hybridoma culture in the CellMaker
Joint Meeting on Vascular Biology, Inflammation and Thrombosis 2020
Meet our USA distributor: nanoscaleLABS
Laborama 2020: 11 & 12 June 2020
CANCELLED: SY-Stem 2020: 25 - 27 March 2020
CellMaker Dual Regular Controller now available
Phage Futures Congress 2020: 5 - 6 February 2020
Distributor Days 2019
Biotechnology Company of the Year 2019
16th Annual bioProcessUK Conference 2019: 26 - 28 November 2019
Meet our distribution network
Phages in Grenoble: 8 - 9 October
Optimising bacteriophage amplification as seen in Capsid and Tail
DiaLabXpo: 24 – 26 September
Phage Futures Europe: 25 - 26 September
Case Study: Bacteriophage amplification results using the CellMaker
Welcome to our new website!
Case Study: Using the CellMaker to produce and increase expression levels of a protein in Pichia pastoris
Case Study: Efficiency of Salmonella enterica serovar Enteritidis bacteriophage amplification using the CellMaker single-use bioreactor system
What is a single-use airlift bioreactor?
A fresh new look for Cellexus

+44 (0)1382 666357
enquiries@cellexus.com

Testimonials

Green Bioactives Ltd aim to develop plant cell culture as a platform to manufacture safe and sustainable plant biomolecules. We grew plant cells using different types of microbial/mammalian cell culture systems, including a 2.5 L stirred bioreactor and a 20L rocking motion bioreactor. We experienced relatively slow plant cell growth rates and a high risk of culture contamination using these two systems.... we came across the Cellexus CellMaker when we were looking to evaluate airlift bioreactors. During the first run in the CellMaker, our plant cells displayed growth rates comparable to the growth rate achieved using shaking flask liquid culture, with the cells reaching a high density. We are now working to improve the process further, testing the CellMaker system with different cell lines, together with evaluating the yield of target high-value molecules. Read the full testimonial

Samuel Casasola-Zamora, Director of Operations, Green-Bioactives Ltd

Using the Cellexus airlift bioreactor, our goals of scaling-up our mycorrhizal fungi liquid fermentation could be easily realised. The size of the reactor and the single-use aspect of the bag meant that we could utilise the unit within our laboratory with minimal effort required.The dissolved oxygen and pH monitoring and control allowed us to characterise our organisms' growth characteristics and has informed our decisions on further scaling-up in the future.

Alex Leman, Bioprocess Engineer, Rhizocore Technologies

We are a small company that needed to quickly upscale. We were looking to increase our production for some large-scale trials, so we were looking for a bioreactor that is easy to manage and set up, but we didn’t have autoclaving facilities. The Cellexus CellMaker ticked all these boxes: we got an increased phage yield, it is compact, the simple interface means we could set it up and leave it alone, plus the sterilised disposable bags cuts out any contamination risks. This will be important for us as we move into practices that require more stringent manufacturing processes, such as the medical field. We have had some fantastic results, increasing our phage production to 1 x 10^13 pfu / ml.

Gordon Smith, Fixed Phage

The CellMaker system has allowed us to grow in scale and to achieve higher productivity. Instead of scaling “out” by using several flasks, we can combine it all in one bag inside the bioreactor. In the 8L bioreactor we can easily get between 3 and 8 litres of phage lysate, and in the 50L bioreactor somewhere between 10 and 50 litres in one go, and with higher phage concentration per unit of volume. The CellMaker was the most cost-effective option on the market for a single-use system with temperature control. It is one of the least expensive I have heard about, and this goes for the bioreactor bags as well. When you balance the cost-benefit, the CellMaker is a good option for phage biotechs.

Dr. Manuel Garrido, Production Specialist, TechnoPhage

We have found the CellMaker reliable, easy to use and invaluable in our antibody production process, with minimal labour required. Our qualified team likes working with this bioreactor, using the advantages of disposable technologies and its precise regulation of biochemical parameters (pH, pO2, temperature). At low-cost and with low labour, the CellMaker rapidly produces large quantities of high-quality antibodies with high specific activity. The CellMaker system is a vital part of the production process of our innovative and unique p53 antibodies.

Dr Jean-Christophe Bourdon, Principal investigator, Head of p53 isoform research group, University of Dundee

We have found the CellMaker reliable, easy to use and invaluable in our Pharmaceutical processes. Our qualified team likes working with this bioreactor, using the advantages of disposable technologies. The CellMaker produces the quantity and quality of bacteriophage that we are looking for. The 4 CellMaker systems have become a vital part of a production process of our innovative BAFASAL® product.

Dr. Arkadiusz Wojtasik, Project Director, Proteon Pharmaceuticals S.A.

© Cellexus | Privacy Policy | Sitemap

Sign up to our newsletter:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.